Held on 10 July 2015
Axis Rail India announced that the Board of Directors of the Company at its meeting held on 10 July 2015, inter alia, has transacted the following businesses:1. Taken on record the demat activation letter received from NSDL and ISIN of the Company (INE078T01018).
2. In continuation to the decisions taken in the Board Meeting held on 17 March 2015 and upon compliance with the stipulation of seeking demat connectivity, the Board of Directors have re-considered and approved the proposal to issue and allot Fully Convertible Warrants to the tune of 33 lakh Warrants to the persons belonging to the Non-Promoter Category, subject to the receipt of approval from the Shareholders in the Extra-Ordinary General Meeting (EGM).
3. Considered and approved the draft Notice calling EGM and authorized the Directors to do all such acts, deeds and things to give effect to the above resolutions.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app